Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Inc

DCPH

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.21B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Deciphera Pharmaceuticals IncDeciphera Pharmaceuticals Inc-11.2--60%12.80.1
$16.90

Current Fair Value

34% downside

Overvalued by 34% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.21 Billion
Enterprise Value$2.15 Billion
Dividend Yield$- (-)
Earnings per Share$-2.29
Beta0.18
Outstanding Shares87,388,106

Return

Return on Equity-60.25%ROE
Return on Assets-45.24%
Return on Invested Capital-61.34%

Valuation & Multiples

P/E Ratio-11.17P/E Ratio
PEG122.39PEG
Price to Sales12.8Price to Sales
Price to Book Ratio8.53Price to Book Ratio
Enterprise Value to Revenue12.27
Enterprise Value to EBIT-10.37
Enterprise Value to Net Income-12
Total Debt to Enterprise0.01
Debt to Equity0.08Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Deciphera Pharmaceuticals Inc

CEO: Steven Hoerter